Somerset Indus Capital Partners 
Dealstreet

ELP advises Somerset Indus Capital Partners in its investment in Natural Biogenex

The investment amount remains undisclosed.

Bar & Bench

Somerset Indus Capital Partners has made an investment in Natural Biogenex Private Limited, a company manufacturing steroidal APIs.

This marks the fund’s sixth overall investment from its Fund II.

Economic Laws Practice advised Somerset Indus Capital Partners in this investment.

The transaction team consisted of Vinay Butani (Partner), Rudraksh Bhatt (Senior Associate) and Faiz Thakur (Senior Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

The silent trial of LinkedIn profiles

The rule that broke the student: Attendance, anxiety and what must change

Judiciary has played a stabilising role in India’s economic transformation: CJI BR Gavai

Between citizenship and cyberspace: Reading the X Corp judgment with constitutional calm

Saraf and Partners' Akshay Jain moves in-house to join Zomato

SCROLL FOR NEXT